These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30915997)

  • 1. Opioid-induced respiratory depression in humans: a review of pharmacokinetic-pharmacodynamic modelling of reversal.
    Algera MH; Kamp J; van der Schrier R; van Velzen M; Niesters M; Aarts L; Dahan A; Olofsen E
    Br J Anaesth; 2019 Jun; 122(6):e168-e179. PubMed ID: 30915997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of opioid-induced respiratory depression by BK-channel blocker GAL021: A pharmacokinetic-pharmacodynamic modeling study in healthy volunteers.
    Roozekrans M; Olofsen E; van der Schrier R; van Gerven J; Peng S; McLeod J; Dahan A
    Clin Pharmacol Ther; 2015 Jun; 97(6):641-9. PubMed ID: 25704491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest.
    van Lemmen M; Florian J; Li Z; van Velzen M; van Dorp E; Niesters M; Sarton E; Olofsen E; van der Schrier R; Strauss DG; Dahan A
    Anesthesiology; 2023 Sep; 139(3):342-353. PubMed ID: 37402248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers.
    Yassen A; Olofsen E; van Dorp E; Sarton E; Teppema L; Danhof M; Dahan A
    Clin Pharmacokinet; 2007; 46(11):965-80. PubMed ID: 17922561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in Reversal Strategies of Opioid-induced Respiratory Toxicity.
    van der Schrier R; Dahan JDC; Boon M; Sarton E; van Velzen M; Niesters M; Dahan A
    Anesthesiology; 2022 Apr; 136(4):618-632. PubMed ID: 34958670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are thyrotropin-releasing hormone (TRH) and analog taltirelin viable reversal agents of opioid-induced respiratory depression?
    Algera MH; Cotten JF; van Velzen M; Niesters M; Boon M; Shoham DS; Dandrea KE; van der Schrier R; Dahan A
    Pharmacol Res Perspect; 2022 Jun; 10(3):e00974. PubMed ID: 35621218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two studies on reversal of opioid-induced respiratory depression by BK-channel blocker GAL021 in human volunteers.
    Roozekrans M; van der Schrier R; Okkerse P; Hay J; McLeod JF; Dahan A
    Anesthesiology; 2014 Sep; 121(3):459-68. PubMed ID: 25222672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-analgesic effects of opioids: opioid-induced respiratory depression.
    Boom M; Niesters M; Sarton E; Aarts L; Smith TW; Dahan A
    Curr Pharm Des; 2012; 18(37):5994-6004. PubMed ID: 22747535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans.
    van Lemmen M; van der Schrier R; Dahan A; van Velzen M; Sarton E; Niesters M
    Expert Opin Drug Metab Toxicol; 2023; 19(10):671-679. PubMed ID: 37795596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Averting Opioid-induced Respiratory Depression without Affecting Analgesia.
    Dahan A; van der Schrier R; Smith T; Aarts L; van Velzen M; Niesters M
    Anesthesiology; 2018 May; 128(5):1027-1037. PubMed ID: 29553984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic pharmacokinetic-pharmacodynamic modeling and simulations of naloxone auto-injector 10 mg reversal of opioid-induced respiratory depression.
    Yang TE; Del Bene F; Lavezzi SM; Iavarone L; Zhang J; Kim J; Gjurich B; Kessler C
    CPT Pharmacometrics Syst Pharmacol; 2024 Oct; 13(10):1722-1733. PubMed ID: 39283753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 5-hydroxytryptamine 4 receptor agonist mosapride does not antagonize morphine-induced respiratory depression.
    Lötsch J; Skarke C; Schneider A; Hummel T; Geisslinger G
    Clin Pharmacol Ther; 2005 Sep; 78(3):278-87. PubMed ID: 16153398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, Reversal, and Prevention of Opioid-induced Respiratory Depression.
    Dahan A; Aarts L; Smith TW
    Anesthesiology; 2010 Jan; 112(1):226-38. PubMed ID: 20010421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The conundrum of polysubstance overdose.
    Pergolizzi JV; Dahan A; LeQuang JA; Raffa RB
    J Clin Pharm Ther; 2021 Oct; 46(5):1189-1193. PubMed ID: 33460173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxapram-mediated Increase in Cardiac Output Reduces Opioid Plasma Concentrations: A Pharmacokinetic/Pharmacodynamic-Pharmacokinetic/Pharmacodynamic Modeling Study in Healthy Volunteers.
    Roozekrans M; Olofsen E; van der Schrier R; Boom M; Mooren R; Dahan A
    Clin Pharmacol Ther; 2017 Jul; 102(1):115-122. PubMed ID: 28001306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esketamine counters opioid-induced respiratory depression.
    Jonkman K; van Rijnsoever E; Olofsen E; Aarts L; Sarton E; van Velzen M; Niesters M; Dahan A
    Br J Anaesth; 2018 May; 120(5):1117-1127. PubMed ID: 29661389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theophylline reverses oxycodone's but not fentanyl's respiratory depression in mice while caffeine is ineffective against both opioids.
    Elder HJ; Walentiny DM; Beardsley PM
    Pharmacol Biochem Behav; 2023 Aug; 229():173601. PubMed ID: 37414364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of Opioid-Induced Respiratory Depression in Healthy Volunteers: Comparison of Intranasal Nalmefene and Intranasal Naloxone.
    Ellison M; Hutton E; Webster L; Skolnick P
    J Clin Pharmacol; 2024 Jul; 64(7):828-839. PubMed ID: 38436495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent.
    Hedrick SL; Luo D; Kaska S; Niloy KK; Jackson K; Sarma R; Horn J; Baynard C; Leggas M; Butelman ER; Kreek MJ; Prisinzano TE
    J Biomed Sci; 2021 Sep; 28(1):62. PubMed ID: 34503531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.